日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Evaluation of Cardiovascular Disease Risk in HIV-1-Infected Patients Treated with Darunavir

达芦那韦治疗 HIV-1 感染患者的心血管疾病风险评估

Opsomer, Magda; Dimitrova, Dessislava; Verspeelt, Johan; Purrington, Amy; Mehbob, Abdul; Chavers, Scott; Pai, Helen; Vanveggel, Simon; Luo, Donghan; Brown, Kimberley; Moecklinghoff, Christiane; Nettles, Richard E; Boven, Katia

Correction to: Evaluation of Cardiovascular Disease Risk in HIV‑1-Infected Patients Treated with Darunavir

更正:达芦那韦治疗 HIV-1 感染患者的心血管疾病风险评估

Opsomer, Magda; Dimitrova, Dessislava; Verspeelt, Johan; Purrington, Amy; Mehbob, Abdul; Chavers, Scott; Pai, Helen; Vanveggel, Simon; Luo, Donghan; Brown, Kimberley; Moecklinghoff, Christiane; Nettles, Richard E; Boven, Katia

TMC278, a next-generation nonnucleoside reverse transcriptase inhibitor (NNRTI), active against wild-type and NNRTI-resistant HIV-1.

TMC278 是一种新一代非核苷类逆转录酶抑制剂 (NNRTI),对野生型和 NNRTI 耐药的 HIV-1 均有效

Azijn Hilde, Tirry Ilse, Vingerhoets Johan, de Béthune Marie-Pierre, Kraus Guenter, Boven Katia, Jochmans Dirk, Van Craenenbroeck Elke, Picchio Gaston, Rimsky Laurence T